Risk of venous thromboembolic events associated with VEGFR-TKIs: a systematic review and meta-analysis
about
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trialsRisk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical TrialsCongestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta-analysis of 36 clinical trials.Risks of proteinuria associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a systematic review and meta-analysisIncreased risk of severe infections in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysisApproach to chemotherapy-associated thrombosis.Risk of venous and arterial thromboembolic events associated with anti-VEGF agents in advanced non-small-cell lung cancer: a meta-analysis and systematic review.Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity.Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials.Risk of hypertension in cancer patients treated with aflibercept: a systematic review and meta-analysis.Risk of gastrointestinal perforation in cancer patients treated with aflibercept: a systematic review and meta-analysis.Novel therapies for thyroid cancer.Sorafenib for the treatment of thyroid cancer: an updated review.Drug safety evaluation of lenvatinib for thyroid cancer.Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer.Cardiovascular adverse effects of targeted antiangiogenic drugs: mechanisms and management.Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in the treatment of advanced thyroid cancer: a meta-analysis of randomized controlled trials.Efficacy of lenvatinib in treating thyroid cancer.Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.Adverse events risk associated with anti-VEGFR agents in the treatment of advanced nonsmall-cell lung cancer: A meta-analysis.Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.Risk of venous and arterial thromboembolic events associated with VEGFR-TKIs: a meta-analysis.Treatment-related mortality with aflibercept in cancer patients: a meta-analysis.Fatal adverse events with molecular targeted agents in the treatment of advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trialsIncidence and risk of thromboembolism associated with bevacizumab in patients with non-small cell lung carcinoma
P2860
Q26822790-77077CB9-3BF1-4276-B6DE-7103B864FE4CQ28551983-5A73B4ED-5A11-41BF-BBA1-02B08778E72AQ34554398-4814DA91-5FD9-4A1E-BFBB-E0F124E29393Q35118673-6651E5DE-5760-4D4D-90AE-5EC0C2D7DC4FQ36024704-4402B084-BC3B-4AB7-94CE-207A6DDB52C2Q36304793-3DFB5F39-8F40-4F9C-A73C-2515A608F695Q37042424-D5C8A402-4432-4940-8C29-8E16AADF6A60Q38155199-4CFF11A9-D2D1-4765-8859-0DEF2381A7A0Q38177768-B12EFC35-DEC5-4B78-807D-4692DBD9701AQ38184936-AB951B6E-6295-4F1E-840D-59FCE9F6C388Q38234800-3F266635-D261-469E-9A27-E818F6B10E3CQ38260495-78EF10F0-E622-4B1F-96DB-3391AC209842Q38326036-9FD3D46E-7E40-489C-9DF1-A17BD8B528B3Q38612008-9B79A1DB-D993-4EEA-9EC8-8BC1E0F6AFDDQ38625034-1D2D3C81-04CB-4611-8599-A507CE4DDCDCQ38744149-0FD2EA64-C06B-49D4-A9FF-AA20F0AC0BDDQ38791974-F7A45E4E-60D2-4209-9DCE-949A8A366AC0Q38843403-D8082699-BBAF-4D69-8DC3-9C2CA239AAEBQ38936104-9B93D660-2C4E-436A-9E74-0B740E0E8C98Q42359608-28296E49-7E4B-4618-9EAF-7E1C70DC0D4DQ45073137-32DF405F-AB48-4712-A335-188764562CD0Q47837536-48C728CF-33B8-40DE-810C-03490F446264Q54386535-7BD5F1B8-5875-47D0-983E-37BDAF8926E1Q57073605-B6D7E9D4-501D-4F90-96F6-E11640536404Q58804445-2E437644-EE11-45BE-BE49-28BFBF9F2727
P2860
Risk of venous thromboembolic events associated with VEGFR-TKIs: a systematic review and meta-analysis
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Risk of venous thromboembolic ...... matic review and meta-analysis
@ast
Risk of venous thromboembolic ...... matic review and meta-analysis
@en
Risk of venous thromboembolic ...... matic review and meta-analysis
@nl
type
label
Risk of venous thromboembolic ...... matic review and meta-analysis
@ast
Risk of venous thromboembolic ...... matic review and meta-analysis
@en
Risk of venous thromboembolic ...... matic review and meta-analysis
@nl
prefLabel
Risk of venous thromboembolic ...... matic review and meta-analysis
@ast
Risk of venous thromboembolic ...... matic review and meta-analysis
@en
Risk of venous thromboembolic ...... matic review and meta-analysis
@nl
P2093
P2860
P31
P3181
P356
P1476
Risk of venous thromboembolic ...... matic review and meta-analysis
@en
P2093
Da-Liu Min
Li-Na Tang
Yuan-Jue Sun
P2860
P304
P3181
P356
10.1002/IJC.27979
P407
P50
P577
2013-06-15T00:00:00Z